Quantcast

Industrial Biotechnology Corp. Reiterated ‘Speculative Buy,’ Target Price $2.20 By Beacon Equity Research

September 8, 2008

Industrial Biotechnology Corp. (Pink Sheets: IBOT) has received a reiterated Speculative Buy rating with a price target of $2.20, by Beacon Analyst Victor Sula, Ph.D.

The full report is available at http://www.beaconequity.com/adpages/IBOT.

Anyone interested in receiving alerts regarding IBOT research should e-mail members@beaconequity.com with “IBOT” in the subject line.

In the report, the analyst writes, “Since our initial report, IBOT’s stock price has increased 10%, from $1.09 to $1.195, mainly as a result of growing interest in the use of sugarcane-based ethanol as a viable feedstock for renewable ethanol and derivate products … The Company has also announced a strategy for importing sugarcane ethanol from Brazil while avoiding the $0.54 ethanol import tariff. This can be accomplished by dehydrating the product in a Caribbean Basin country.”

Other companies in the renewable energy sector include: Verasun Energy Corp. (NYSE: VSE), Aventine Renewable Energy (NYSE: AVR), Sigma-Aldrich Corp. (Nasdaq: SIAL) and Hercules Inc. (NYSE: HPC).

Beacon Equity Research Disclosure

The report is a service of BlueWave Advisors, LLC, a financial public relations firm that has been compensated by the companies profiled. All direct and third party compensation received has been disclosed within each individual profile in accordance with section 17(b) of the Securities Act of 1933. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. BlueWave Advisors, LLC, and/or its affiliated will hold, buy, and sell securities in the companies profiled. When compensated in shares, all readers should be aware that is our policy to liquidate all shares immediately. We reserve the right to buy or sell the shares of any the companies mentioned in any materials we produce at any time. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. BeaconEquity.com is a Web site wholly-owned by BlueWaveAdvisors, LLC. BlueWave Advisors, LLC has been compensated forty seven thousand five hundred dollars from Rovert Consulting, a shareholder of IBOT.




comments powered by Disqus